BioSpace News Archive

Since its inception, Jacoti has made quality and regulatory compliance a priority.

Aprea Therapeutics announced that funds managed by Janus Henderson Investors joined its Series C financing as a new investor, raising the total amount of the financing to EUR 55 million.

Alex Turnbull, NZMP Marketing Director, says the trends are helping to shape the global FMCG marketplace, with NZMP at the forefront of delivering to the trends in all of its markets.

Quest Diagnostics, the world’s leading provider of diagnostic information services, and Regional Medical Center of Orangeburg, S.C., are teaming up to enhance the quality and value of diagnostic services for patients and their doctors through a new partnership agreement under which Quest will provide full laboratory management services.

United Therapeutics Corporation announced its financial results for the fourth quarter and year ended December 31, 2018.

LivaNova PLC, a market-leading medical technology and innovation company, reported results for the quarter and full-year ended December 31, 2018.

Ionis Pharmaceuticals, Inc. reported financial results for the fourth quarter and full year 2018 and reviewed highlights of its successful year.

DURECT Corporation announced it has completed a comprehensive review of its POSIMIR® program and plans to submit a full response to the Complete Response Letter it previously received from U.S. Food and Drug Administration.

Intec Pharma Ltd. announces financial results for the fourth quarter and year ended December 31, 2018 and provides a corporate update.

Alpine Immune Sciences, Inc. announced the company will participate in two upcoming investor conferences in March.